Insight Pharmaceuticals has recalled 34,092 bottles of Nostrilla, a nasal decongestant (oxymetazoline) spray used to relieve nasal discomfort caused by colds, because the spray may contain bacteria.
The bacteria, Burkholderia cepacia, may cause serious infection in individuals with a compromised immune system or chronic lung condition, such as cystic fibrosis.
Nostrilla Nasal Decongestant was distributed nationwide through retail outlets and pharmacies. The spray comes in a half ounce, plastic bottle marked with an expiration date of May, 2014.The affected products also have lot number 11G075, and UPC code 6373673005.
Consumers who purchased Nostrilla can return the product, and also contact the company at 877-546-9059 for more information. Consumers should also contact their physician or healthcare provider if they experience any problems that may be related to taking the recalled nasal spray. Healthcare professionals and patients can report adverse events or side effects to the U.S. Food and Drug Administration’s MedWatch Safety Information and Adverse Event Reporting Program, either by visiting , or call by calling 800-332-1088 to get a form sent to you by mail.
Similar Posts:
- What is the biggest no brainer thing to do to make my home Green?
- I have no insulation in my walls. What are the best insulation options for my home, which was built in 1926?
- I need a new water filtration system on our well at home and was wondering what the least toxic systems are. Any ideas?
- I can’t find anyone who can install a rainwater collection system. I have plumbed my house to use rainwater for flushing.
- Pool Return Leak
